• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

2VS:GR

6.513 EUR 0.136 2.05%

As of 02:14:07 ET on 09/01/2014.

Snapshot for Verastem Inc (2VS)

Open: 6.513 Day's Range: 6.513 - 6.513 Volume: 0
Previous Close: 6.649 52wk Range: 5.056 - 12.058 1-Yr Rtn: -36.71%

Stock Chart for 2VS

No chart data available.
  • 2VS:GR 6.513
  • 1M
  • 1Y
6.649
Interactive 2VS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2VS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.0940
Est. PEG Ratio -
Market Cap (M EUR) 168.31
Shares Outstanding (M) 25.84
30 Day Average Volume 80
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2VS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 2VS

Verastem Inc., is a clinical biopharmaceutical company. The Company focuses on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Verastem also develops proprietary companion diagnostics for stem cells. The Company's technology allows the creation of stable programs for various signaling pathways.

Christoph H WestphalChairman/Co-FounderRobert ForresterPresident/CEO
John B Green "Jack"Chief Financial OfficerDaniel PatersonChief Business Officer
More Company Profile & Key Executives for 2VS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil